Cogent Biosciences, Inc. (COGT) Ownership

$8.06

north_east
$0.18 (2.28%)
Day's range
$7.91
Day's range
$8.57

Cogent Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/13/2025 16.57 M $129.24 M   99.16% 15.04%
KYNAM CAPITAL MANAGEMENT, LP 02/14/2025 9.11 M $71.02 M   -1.46% 8.26%
BLACKROCK FUNDING, INC. /DE 02/07/2025 8.34 M $65.05 M   4.35% 7.57%
TCG CROSSOVER MANAGEMENT, LLC 02/14/2025 6.96 M $54.32 M   0.00% 6.32%
COMMODORE CAPITAL LP 02/14/2025 6.88 M $53.68 M   -8.73% 6.25%
FAIRMOUNT FUNDS MANAGEMENT LLC 02/14/2025 6.23 M $48.56 M   0.00% 5.65%
VANGUARD GROUP INC 02/11/2025 6.13 M $47.84 M   7.33% 5.57%
VR ADVISER, LLC 02/14/2025 5.68 M $44.34 M   0.00% 5.16%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 5.35 M $41.71 M   -48.93% 4.85%
PARADIGM BIOCAPITAL ADVISORS LP 02/14/2025 4.92 M $38.36 M   6.67% 4.46%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 4.30 M $33.54 M   5.75% 3.90%
STATE STREET CORP 02/14/2025 3.92 M $30.56 M   21.25% 3.56%
REDMILE GROUP, LLC 02/14/2025 3.55 M $27.73 M   -20.73% 3.23%
OCTAGON CAPITAL ADVISORS LP 02/14/2025 2.76 M $21.55 M   111.72% 2.51%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/14/2025 2.63 M $20.52 M   -29.73% 2.39%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 2.31 M $18.01 M   1.22% 2.10%
SATURN V CAPITAL MANAGEMENT LLC 02/14/2025 1.50 M $11.69 M   -12.52% 1.36%
FRANKLIN RESOURCES INC 02/12/2025 1.28 M $10.01 M   28.35% 1.17%
VIVO CAPITAL, LLC 02/13/2025 1.12 M $8.76 M   0.00% 1.02%
WALLEYE CAPITAL LLC 02/13/2025 936,791 $7.31 M   68.09% 0.85%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/18/2025 936,576 $7.31 M   0.00% 0.85%
SILVERARC CAPITAL MANAGEMENT, LLC 02/14/2025 921,137 $7.18 M   -24.58% 0.84%
SUPERSTRING CAPITAL MANAGEMENT LP 02/14/2025 910,865 $7.10 M   100.00% 0.83%
GOLDMAN SACHS GROUP INC 02/11/2025 864,893 $6.75 M   -1.50% 0.79%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/14/2025 852,855 $6.65 M   7.83% 0.77%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 833,155 $6.50 M   0.89% 0.76%
SOFINNOVA INVESTMENTS, INC. 02/14/2025 823,160 $6.42 M   -63.66% 0.75%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 743,652 $5.80 M   -6.15% 0.68%
WOODLINE PARTNERS LP 02/14/2025 613,165 $4.78 M   2.10% 0.56%
02/13/2025 548,554 $4.28 M   100.00% 0.50%
READYSTATE ASSET MANAGEMENT LP 02/14/2025 520,000 $4.06 M   100.00% 0.47%
ASSENAGON ASSET MANAGEMENT S.A. 01/14/2025 473,693 $3.69 M   -21.99% 0.43%
ALLIANCEBERNSTEIN L.P. 02/12/2025 464,942 $3.63 M   466.59% 0.42%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2025 457,048 $3.56 M   -1.11% 0.41%
CRESTLINE MANAGEMENT, LP 02/14/2025 369,763 $2.88 M   0.00% 0.34%
ALGERT GLOBAL LLC 02/14/2025 344,235 $2.69 M   92.28% 0.31%
D. E. SHAW & CO., INC. 02/14/2025 339,988 $2.65 M   -25.64% 0.31%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 313,099 $2.44 M   -0.60% 0.28%
AVIDITY PARTNERS MANAGEMENT LP 02/14/2025 287,104 $2.24 M   -71.32% 0.26%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 284,850 $2.22 M   -16.79% 0.26%
HIGHVISTA STRATEGIES LLC 02/14/2025 279,673 $2.18 M   23.95% 0.25%
TREXQUANT INVESTMENT LP 02/12/2025 277,523 $2.16 M   184.45% 0.25%
HENNION & WALSH ASSET MANAGEMENT, INC. 01/15/2025 275,292 $2.15 M   60.05% 0.25%
BANK OF NEW YORK MELLON CORP 02/04/2025 258,766 $2.02 M   -1.83% 0.23%
NEW LEAF VENTURE PARTNERS, L.L.C. 02/13/2025 250,765 $1.96 M   0.00% 0.23%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 242,929 $1.89 M   100.00% 0.22%
MACQUARIE GROUP LTD 02/14/2025 230,000 $1.79 M   0.00% 0.21%
UBS GROUP AG 02/14/2025 213,934 $1.67 M   85.23% 0.19%
CAPTION MANAGEMENT, LLC 02/14/2025 202,500 $1.58 M   100.00% 0.18%
BARCLAYS PLC 02/13/2025 193,068 $1.51 M   9.90% 0.18%

Cogent Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 198 institutional investors and hedge funds held shares of Cogent Biosciences, Inc.. The most heavily invested institutionals were:

FMR LLC: 16.57 M

Kynam Capital Management, LP: 9.11 M

BlackRock Funding, Inc. /DE: 8.34 M

TCG Crossover Management, LLC: 6.96 M

COMMODORE CAPITAL LP: 6.88 M

Fairmount Funds Management LLC: 6.23 M

110.48% of Cogent Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 128.89 M shares in the last 24 months. This purchase volume represents approximately $1.04 B in transactions.